1996
DOI: 10.1002/(sici)1097-4644(199607)62:1<123::aid-jcb13>3.0.co;2-o
|View full text |Cite
|
Sign up to set email alerts
|

Non-RGD domains of osteopontin promote cell adhesion without involving αv integrins

Abstract: Osteopontin (OPN) is an integrin-binding secreted protein that contains an Arg-Gly-Asp (RGD) amino acid sequence and binds to various cell types via RGD-mediated interaction with the alpha v beta 3 integrin. We have identified a cell line whose binding to OPN does not require RGD or alpha v interactions. We compared the ability of two murine cell lines, L929 fibroblastic cells and B16-BL6 melanoma cells, to interact with OPN (from human milk, and recombinant human and mouse OPN) as well as recombinant OPN prep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

1998
1998
2006
2006

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 50 publications
(26 citation statements)
references
References 21 publications
0
26
0
Order By: Relevance
“…It appears that OPN mainly interacts with CD44 and not with one of its other receptor targets, namely a v b 1 , a v b 3 or a v b 5 , to facilitate H-RasV12-mediated transformation of NIH3T3 cells. Evidence in support of our position come from the following observations: (1) CD44 blocking antibody impaired both foci formation and invasion; (2) knockdown of OPN expression by RNAi disrupted both foci formation and invasion; (3) foci formation and invasion were not impeded by blockade of the integrins with the GRGDS peptide; (4) H-RasV12 must upregulate OPN and an additional component(s) to initiate transformation since OPN was not sufficient on its own to stimulate foci formation, OPN plus H-RasV12 synergistically stimulated foci formation, and CD44 but not the a v -containing integrins was upregulated by H-RasV12; (5) RGDdeficient OPN which cannot interact with the integrins (Katagiri et al, 1996) was shown to bind to H-RasV12-transformed but not control NIH3T3 cells; and (6) RGD-deficient OPN-binding activity to H-RasV12-transformed cells was inhibited by the CD44 blocking antibody.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It appears that OPN mainly interacts with CD44 and not with one of its other receptor targets, namely a v b 1 , a v b 3 or a v b 5 , to facilitate H-RasV12-mediated transformation of NIH3T3 cells. Evidence in support of our position come from the following observations: (1) CD44 blocking antibody impaired both foci formation and invasion; (2) knockdown of OPN expression by RNAi disrupted both foci formation and invasion; (3) foci formation and invasion were not impeded by blockade of the integrins with the GRGDS peptide; (4) H-RasV12 must upregulate OPN and an additional component(s) to initiate transformation since OPN was not sufficient on its own to stimulate foci formation, OPN plus H-RasV12 synergistically stimulated foci formation, and CD44 but not the a v -containing integrins was upregulated by H-RasV12; (5) RGDdeficient OPN which cannot interact with the integrins (Katagiri et al, 1996) was shown to bind to H-RasV12-transformed but not control NIH3T3 cells; and (6) RGD-deficient OPN-binding activity to H-RasV12-transformed cells was inhibited by the CD44 blocking antibody.…”
Section: Discussionmentioning
confidence: 99%
“…Wild-type OPN interacts with CD44 in an RGDindependent manner and with the integrins through its RGD domain, thus the RGD-deficient OPN will only bind to CD44 (Katagiri et al, 1996). In the absence of antibody pretreatment or presence of negative control ERK2 antibody, the vast majority of adherent HRasV12-transformed cells bound mutant OPN (compare DAPI staining in lower panel with corresponding upper panel depicting the same cells bound to fluorescent OPN, Figure 3a).…”
Section: Binding Of Rgd-deficient Opn To Cd44 In Nih3t3 Cellsmentioning
confidence: 99%
“…15 Recombinant human PDGF-BB was purchased from R&D Systems. A monoclonal anti-rat OPN antibody (MPIIIB10) was from American Research Products.…”
Section: Reagentsmentioning
confidence: 91%
“…51 At a multiplicity of infection of 10 000 VP/cell, gene transfer with the RGD-negative AE74 and AE73 viruses was slightly above the background, whatever the length of incubation time. In contrast, the control vector AE18 was able to achieve significant gene transfer at that high MOI, and increasing the incubation time from 1 to 48 h improved transduction by 5.6-fold.…”
Section: Infection Of Car-positive or -Negative Cells With Modified Vmentioning
confidence: 99%